The NHLBI Innovation and Commercialization Office (I&C) helps a diverse pool of extramural academic and small business innovators accelerate the transition of their new and promising discoveries into biomedical products that prevent, diagnose, and treat heart, lung, blood, and sleep diseases and disorders. I&C provides pre-application advice to innovators, offers product development support during funding periods, and helps identify potential federal and private sector partners that may support further technology development.
I&C coordinates and serves as a central point of contact for the NHLBI Small Business Program, which includes both Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) activities. I&C also facilitates alliances with federal and private sector partners, contributes to collaborative projects and initiatives that support innovators, and lends its expertise to other NIH and NHLBI programs that work with them.
Potential applicants for Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) funding receive guidance on their funding proposals and answers to application questions.
New or previously unfunded applicants for SBIR/STTR funding may apply to receive an NHLBI Research Supplement through the NIH Applicant Assistance Program (AAP) for New or Previously Unawarded Small Businesses, an initiative supported by NHLBI and managed by I&C.
- Yasamin Moghadam
- NHLBI AAP Coordinator
The NHLBI is interested in Small Business Innovation Research/Small Business Technology Transfer (SBIR/STTR) activities that advance the prevention, diagnosis, and treatment of heart, lung, blood, and sleep disorders. View funding information for the NHLBI Small Business Program.
Academic and small business innovators currently funded with NHLBI SBIR/STTR awards may apply for the following resources to advance their heart, lung, blood, and sleep innovations:
I&C’s Awardee Product Development Advisory Services
- Product development mentorship. Scientific, business, and investor experts help facilitate the commercialization of innovations through Entrepreneurs-in-Residence (EIR) and/or mentor network consultations.
- Pitch coaching and conference support. Select NHLBI SBIR/STTR awardees receive conference registration fee support, coaching to improve their business development and pitch presentations, and opportunities to spotlight innovations at conference “showcases.”
Contact: Julia Berzhanskaya, Ph.D., Innovator Support Coordinator, firstname.lastname@example.org
I&C-supported Awardee Opportunities
- NIH Research Supplements to Promote Diversity in Health-Related Research opportunities for those with active NHLBI funding. Eligible small business awardees may apply to receive supplemental funding to hire trainees from underrepresented communities who can advance research projects and increase diversity in the research workforce.
- Innovation Corps (I-Corps™) at NIH Program. Currently funded SBIR/STTR Phase I grantees may apply to receive supplemental awards that include an entrepreneurial immersion course and support for travel and other training program costs. The program fosters the development of early-stage biomedical technologies, teaches researchers how to gain a clearer understanding of the value of their inventions in the marketplace, and educates researchers about ways to move their technologies from the research lab into the commercial world.
- Concept to Clinic: Commercializing Innovation (C3i) Program. In this NIH program led by the National Institute of Biomedical Imaging and Bioengineering. NIH-supported investigators may apply to participate in one of three components: a 10-week online entrepreneurial education platform, a 24-week in-depth entrepreneurial training experience in validation/execution, or a 12-month product development and business support acceleration program.
- SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance and Late Stage Development. The CRP program supports innovations that were previously or are currently funded SBIR/STTR Phase II and Phase IIB projects by helping transition these projects to the commercialization stage. It does this by providing additional support for technical assistance and later stage research and development not typically supported through Phase II or Phase IIB grants or contracts. Applicants only interested in technical assistance may make a request through the SBIR/STTR Commercialization Readiness Pilot Program Technical Assistance.
- NIH Technical and Business Assistance (TABA) Programs. NHLBI small business awardees may apply to these programs for help in identifying and addressing their most pressing product development needs. The programs offer funding, needs assessments, and consulting services. Contact: Stephanie Davis, Ph.D., Small Business Program Coordinator, email@example.com
Product and Business Development Resources (for Applicants and Awardees)
Digital Education (videos)
Available to all, these videos offer guidance on a broad range of product and business development topics (e.g., improving one’s business pitch, patent litigation) relevant to NHLBI innovators. Videos can be viewed by going to the I&C’s playlist on NHLBI’s YouTube channel.
I&C works closely with SBIR and STTR offices at other NIH institutes, offices, and centers, as well as the NIH Small business Education and Entrepreneurial Development (SEED) group. To connect innovators to online resources that can help them translate their discoveries into biomedical products, these offices compiled a list of useful links with answers to common questions. Innovators can find an array of information about protecting intellectual property, among other topics, as well as relevant guidance documents and points of contact at the Food and Drug Administration (FDA).
Support for Other NIH and NHLBI Programs
I&C coordinates SBIR/STTR activities across NHLBI, and lends its expertise to other programs that support academic and small business innovators, including Catalyze and the Center for Advancing Point of Care Technologies in Heart, Lung, Blood, and Sleep Diseases (CAPCaT).
I&C also provides support to the NIH Centers for Accelerated Innovations (NCAI) and NIH Research Evaluation and Commercialization Hubs (REACH). These programs help translate selected academic discoveries into commercial products through entrepreneurial training, feedback from federal and industry experts, funding to support early-stage product definition studies, and project management support.